TERT and metabolic dysfunction-associated steatotic liver disease: AUROC, sensitivity, specificity, PPV, and NPV of TERT C228T were 0.812, 63.9%, 95.2%, 95.8%, and 60.6% in predicting NAFLD-related liver cancer, respectively.